Radiotherapy plus chemotherapy with or without surgical resection for stage III non-small-cell lung cancer: a phase III randomised controlled trial-Reference-Cited by-同舟云学术

Radiotherapy plus chemotherapy with or without surgical resection for stage III non-small-cell lung cancer: a phase III randomised controlled trial

Published:2009-08 Issue:9687 Volume:374 Page:379-386
ISSN:0140-6736
Container-title:The Lancet
language:en
Short-container-title:The Lancet

Author:

Albain Kathy S,Swann R Suzanne,Rusch Valerie W,Turrisi Andrew T,Shepherd Frances A,Smith Colum,Chen Yuhchyau,Livingston Robert B,Feins Richard H,Gandara David R,Fry Willard A,Darling Gail,Johnson David H,Green Mark R,Miller Robert C,Ley Joanne,Sause Willliam T,Cox James D

Publisher

Elsevier BV

Subject

General Medicine

Reference25 articles.

1. Prognostic implications of the International Staging System for lung cancer;Mountain;Semin Oncol,1988

2. The role of surgery in N2 lung cancer;Martini;Surg Clin North Amer,1987

3. Long-term observations of the patterns of failure in patients with unresectable non-oat cell carcinoma of the lung treated with definitive radiotherapy. Report by the Radiation Therapy Oncology Group;Perez;Cancer,1987

4. Thoracic radiotherapy does not prolong survival in patients with locally advanced, unresectable non-small cell lung cancer;Johnson;Annals Int Med,1990

5. A randomized trial of induction chemotherapy plus high-dose radiation versus radiation alone in stage III non-small-cell-lung cancer;Dillman;N Engl J Med,1990

Cited by 1256 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Training robust T1-weighted magnetic resonance imaging liver segmentation models using ensembles of datasets with different contrast protocols and liver disease etiologies;Scientific Reports;2024-09-09

2. Real-World Analysis of Survival and Treatment Efficacy in Stage IIIA-N2 Non-Small Cell Lung Cancer;Cancers;2024-09-02

3. Pneumonectomy for non–small cell lung cancer. A National Cancer Database analysis of geographic and temporal trends, outcomes, and associated factors;Surgery;2024-09

4. Prognostic factors in clinical stage IIIA small cell lung cancer: An analysis of a population-based cancer registry in Taiwan;PLOS ONE;2024-08-29

5. Survivorship program including long‐term toxicities and quality‐of‐life development over 10 years in a randomized trial in operable stage III non‐small‐cell lung cancer (ESPATUE);International Journal of Cancer;2024-08-28